| Key Financial Ratios of Gland Pharma (in Rs. Cr.) |
Mar 23 |
Mar 22 |
Mar 21 |
Mar 20 |
Mar 19 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
47.12 |
73.84 |
63.07 |
49.88 |
29.16 |
|
| Diluted EPS (Rs.) |
47.11 |
73.67 |
62.99 |
49.88 |
29.16 |
|
| Cash EPS (Rs.) |
56.01 |
80.49 |
66.98 |
55.98 |
344.54 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
482.90 |
435.68 |
360.86 |
235.32 |
1,847.12 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
482.90 |
435.68 |
360.86 |
235.32 |
1,847.12 |
|
| Dividend / Share(Rs.) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Revenue from Operations/Share (Rs.) |
219.58 |
267.85 |
211.68 |
169.94 |
1,319.27 |
|
| PBDIT/Share (Rs.) |
76.44 |
105.57 |
87.84 |
70.64 |
511.05 |
|
| PBIT/Share (Rs.) |
67.53 |
98.86 |
81.81 |
64.54 |
458.16 |
|
| PBT/Share (Rs.) |
63.66 |
98.54 |
81.60 |
64.08 |
442.95 |
|
| Net Profit/Share (Rs.) |
47.11 |
73.78 |
60.95 |
49.88 |
291.65 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
34.81 |
39.41 |
41.49 |
41.56 |
38.73 |
|
| PBIT Margin (%) |
30.75 |
36.90 |
38.64 |
37.97 |
34.72 |
|
| PBT Margin (%) |
28.98 |
36.79 |
38.54 |
37.70 |
33.57 |
|
| Net Profit Margin (%) |
21.45 |
27.54 |
28.79 |
29.35 |
22.10 |
|
| Return on Networth / Equity (%) |
9.75 |
16.93 |
16.88 |
21.19 |
15.78 |
|
| Return on Capital Employed (%) |
13.82 |
22.39 |
22.36 |
26.83 |
23.74 |
|
| Return on Assets (%) |
8.84 |
15.47 |
15.34 |
18.91 |
12.82 |
|
| Total Debt/Equity (X) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Asset Turnover Ratio (%) |
0.44 |
0.61 |
53.30 |
64.44 |
58.03 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
9.43 |
10.04 |
10.00 |
7.93 |
4.43 |
|
| Quick Ratio (X) |
6.77 |
8.01 |
7.51 |
5.82 |
2.71 |
|
| Inventory Turnover Ratio (X) |
1.10 |
1.66 |
2.72 |
3.48 |
2.24 |
|
| Dividend Payout Ratio (NP) (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Dividend Payout Ratio (CP) (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Earnings Retention Ratio (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Cash Earnings Retention Ratio (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
17,130.67 |
50,630.26 |
37,533.06 |
0.00 |
0.00 |
|
| EV/Net Operating Revenue (X) |
4.74 |
11.51 |
10.84 |
0.00 |
0.00 |
|
| EV/EBITDA (X) |
13.61 |
29.19 |
26.12 |
0.00 |
0.00 |
|
| MarketCap/Net Operating Revenue (X) |
5.78 |
12.21 |
11.71 |
0.00 |
0.00 |
|
| Retention Ratios (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Price/BV (X) |
2.63 |
7.50 |
6.87 |
0.00 |
0.00 |
|
| Price/Net Operating Revenue |
5.78 |
12.21 |
11.71 |
0.00 |
0.00 |
|
| Earnings Yield |
0.04 |
0.02 |
0.02 |
0.00 |
0.00 |
|
Source : Dion Global Solutions Limited
